Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Giant Biogene Holding CoHKSE:02367 +0.66%85 Days Inventory is 148.76 as of Dec. 2025, which is 28% above its 10-year median of 116.29. GuruFocus rates HKSE:02367 with a GF Score™ of 85/100 and a GF Value™ of HK$68.00 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,891 Consumer Packaged Goods companies, Giant Biogene Holding Co ranks worse than 71.29% on this metric.
The historical rank and industry rank for Giant Biogene Holding Co's Days Inventory or its related term are showing as below:
HKSE:02367'
s Days Inventory Range Over the Past 10 Years
Min: 94.97 Med: 116.29 Max: 139.99
Current: 127.58
During the past 7 years, Giant Biogene Holding Co's highest Days Inventory was 139.99. The lowest was 94.97. And the median was 116.29.
HKSE:02367's Days Inventory is ranked worse than 71.29% of 1891
companies
in the Consumer Packaged Goods industry
Industry Median: 82.66
vs HKSE:02367: 127.58
Inventory Turnover measures how fast the company turns over its inventory within a year.
Giant Biogene Holding Co's Inventory Turnover for the
six
months ended in Dec. 2025 was 1.23.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Giant Biogene Holding Co's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.17.
Giant Biogene Holding Co (HKSE:02367) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Giant Biogene Holding Co's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Giant Biogene Holding Co's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Giant Biogene Holding Co Days Inventory Related Terms
Giant Biogene Holding Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02367 vs PG, CL, EL: Days Inventory Comparison
For the Household & Personal Products subindustry, Giant Biogene Holding Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Giant Biogene Holding Co Days Inventory vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Giant Biogene Holding Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Giant Biogene Holding Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Giant Biogene Holding Co (HKSE:02367) has a Days Inventory of 148.76 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Giant Biogene Holding Co and its competitors. This is 28% above median its historical median of 116.29. Over the past decade, Giant Biogene Holding Co's Days Inventory has ranged from 94.97 to 139.99. According to the industry distribution chart, Giant Biogene Holding Co ranks #1348 out of 1891 companies in the Consumer Packaged Goods industry, placing it in the top 71.3%.
Is Giant Biogene Holding Co's Days Inventory too high?
Giant Biogene Holding Co's current Days Inventory of 148.76 is 28% above median its 10-year median of 116.29. Over the past 10 years, this metric has ranged from a low of 94.97 to a high of 139.99. The Consumer Packaged Goods industry median Days Inventory is 82.66. Giant Biogene Holding Co's value of 148.76 is 80% above this industry median. Based on the distribution chart, Giant Biogene Holding Co ranks #1348 out of 1891 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Giant Biogene Holding Co has a GF Score™ of 85/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Giant Biogene Holding Co's Days Inventory compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Giant Biogene Holding Co ranks #1348 out of 1891 companies for Days Inventory. This places Giant Biogene Holding Co in the lower half of its industry. The industry median Days Inventory is 82.66. Giant Biogene Holding Co's value of 148.76 is 80% above this benchmark. Historically, Giant Biogene Holding Co's own Days Inventory has ranged from 94.97 to 139.99 over the past decade. While the company's 10-year median is 116.29 vs. the industry median of 82.66, Giant Biogene Holding Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Consumer Packaged Goods company?
The median Days Inventory among Consumer Packaged Goods companies is 82.66, based on 1,891 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Giant Biogene Holding Co's current Days Inventory of 148.76 is 80% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Giant Biogene Holding Co and its competitors. For the Consumer Packaged Goods industry, the median Days Inventory is 82.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Giant Biogene Holding Co's current Days Inventory is 148.76, which is 28% above median its own 10-year median of 116.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Giant Biogene Holding Co stock overvalued right now?
Based on GuruFocus' analysis, Giant Biogene Holding Co (HKSE:02367) is currently considered Possible Value Trap. The stock's GF Value™ is HK$68.00, compared to a current price of HK$24.32 — trading 64.2% below its estimated fair value. The current Days Inventory is 148.76, which is 28% above median its 10-year median of 116.29 and 80% above the Consumer Packaged Goods industry median of 82.66. Giant Biogene Holding Co's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Giant Biogene Holding Co (HKSE:02367), the current Days Inventory is 148.76 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Giant Biogene Holding Co (HKSE:02367) Overvalued in 2026?
Based on GuruFocus' analysis, Giant Biogene Holding Co stock appears to be undervalued.
The current stock price of HK$24.32 is trading 64.2% below its estimated GF Value™ of HK$68.00.
GuruFocus considers Giant Biogene Holding Co to be Possible Value Trap.
Key valuation signals for HKSE:02367:
Days Inventory: 148.76 (28% above median its 10-year median of 116.29)
GF Value™: HK$68.00 vs. price of HK$24.32 (64.2% below fair value)
Industry Position: 80% above the Consumer Packaged Goods median (#1348 of 1891)
No single metric tells the full story. See the HKSE:02367 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Giant Biogene Holding Co Ltd designs, develops, and manufactures professional skin treatment products with recombinant collagen as the key bioactive ingredient. The company also develops and manufactures rare ginsenoside technology-based functional foods. The company utilizes proprietary synthetic biology technology to develop & manufacture multiple types of recombinant collagen & rare ginsenosides in-house. Bioactive ingredients offer a wealth of beauty & health properties such as skin repair, anti-aging, whitening, moisturizing, & immunity improvement, with a broad range of applications in the beauty & health sectors. The group is organised into a single business unit that mainly includes the research, development, manufacture, & sale of bioactive material-based beauty & health products.
85GF Score
Get the complete analysis for HKSE:02367
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02367 has been successfully added to your 
